Abstract
Diabetes mellitus is a complex metabolic disorder characterized by chronic hyperglycemia and vascular complications, leading to significant morbidity and mortality. All forms of diabetes are ultimately related to insufficient functional pancreatic β-cell mass to maintain euglycemia. In this context, the promotion of β-cell survival and function is a fundamental issue of direct relevance to diabetes prevention and treatment. Although first identified as a hematopoietic factor that promotes erythropoiesis and erythrocyte survival, an accumulating body of evidence suggests that erythropoietin (EPO) may also exert cytoprotective effects on non-erythroid tissues, including the brain, kidney, blood vessels, and pancreatic β cells. Recent reports have demonstrated the biological effects of EPO on the pancreatic β cells and its potential preventative and therapeutic role in diabetes. This review will focus on the emerging extra-hematopoietic roles of EPO and its potential protective role in diabetes.
Keywords: Angiogenesis, Apoptosis, Diabetes, Erythropoietin, Pancreatic beta cell, rHuEPO, Chronic hyperglycemia, Vascular complications, Euglycemia, Erythropoiesis
Current Diabetes Reviews
Title: The Extra-Hematopoietic Role of Erythropoietin in Diabetes Mellitus
Volume: 7 Issue: 4
Author(s): Diana Choi, Ravi Retnakaran and Minna Woo
Affiliation:
Keywords: Angiogenesis, Apoptosis, Diabetes, Erythropoietin, Pancreatic beta cell, rHuEPO, Chronic hyperglycemia, Vascular complications, Euglycemia, Erythropoiesis
Abstract: Diabetes mellitus is a complex metabolic disorder characterized by chronic hyperglycemia and vascular complications, leading to significant morbidity and mortality. All forms of diabetes are ultimately related to insufficient functional pancreatic β-cell mass to maintain euglycemia. In this context, the promotion of β-cell survival and function is a fundamental issue of direct relevance to diabetes prevention and treatment. Although first identified as a hematopoietic factor that promotes erythropoiesis and erythrocyte survival, an accumulating body of evidence suggests that erythropoietin (EPO) may also exert cytoprotective effects on non-erythroid tissues, including the brain, kidney, blood vessels, and pancreatic β cells. Recent reports have demonstrated the biological effects of EPO on the pancreatic β cells and its potential preventative and therapeutic role in diabetes. This review will focus on the emerging extra-hematopoietic roles of EPO and its potential protective role in diabetes.
Export Options
About this article
Cite this article as:
Choi Diana, Retnakaran Ravi and Woo Minna, The Extra-Hematopoietic Role of Erythropoietin in Diabetes Mellitus, Current Diabetes Reviews 2011; 7(4) . https://dx.doi.org/10.2174/157339911796397820
DOI https://dx.doi.org/10.2174/157339911796397820 |
Print ISSN 1573-3998 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6417 |

- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Advanced Glycation Endproducts and Diabetes. Beyond Vascular Complications
Endocrine, Metabolic & Immune Disorders - Drug Targets Clinical Measures of Islet Function: Usefulness to Characterize Defects in Diabetes
Current Diabetes Reviews The Woman’s Heart: Insights into New Potential Targeted Therapy
Current Medicinal Chemistry Therapies Targeting Inflammation After Stent Implantation
Current Vascular Pharmacology The Pentacyclic Triterpenoids in Herbal Medicines and Their Pharmacological Activities in Diabetes and Diabetic Complications
Current Medicinal Chemistry Amino Thiols, Detoxification and Oxidative Stress in Pre-Eclampsia and Other Disorders of Pregnancy
Current Pharmaceutical Design Targeting Platelet G-Protein Coupled Receptors (GPCRs): Looking Beyond Conventional GPCR Antagonism
Current Vascular Pharmacology Improving Adherence to Antipsychotic Pharmacotherapy
Current Clinical Pharmacology GDF 15 - A Novel Biomarker in the Offing for Heart Failure
Current Cardiology Reviews Acute Severe Colitis: Infliximab and/or Cyclosporine?
Current Drug Targets The Added Value of Oral Glucose Tolerance Testing in Pre-Diabetes
Current Diabetes Reviews Myocardial Perfusion and Coronary Vasomotor Function: Emerging Role of PET Imaging
Vascular Disease Prevention (Discontinued) Hypothalamic and Neuroendocrine Changes in Huntingtons Disease
Current Drug Targets The Antioxidant Activity of Coumarins and Flavonoids
Mini-Reviews in Medicinal Chemistry Retrospective, Observation Study: Quantitative and Qualitative Effect of Ezetimibe and HMG-CoA Reductase Inhibitors on LDL-Cholesterol: Are There Disappearance Thresholds for Small, Dense LDL and IDL?
Recent Patents on Cardiovascular Drug Discovery SGLT-2 inhibitors in Diabetic Kidney Disease: What Lies Behind their Renoprotective Properties?
Current Medicinal Chemistry Addressing Alzheimer’s Disease and Cognitive Loss through Autophagy
Current Neurovascular Research Synthesis, Biological Evaluation, and QPLD Studies of Piperazine Derivatives as Potential DPP-IV Inhibitors
Medicinal Chemistry Surreptitious TB Infections with Recently Identified DM People: A Cross- Sectional Study
Infectious Disorders - Drug Targets Mediterranean Diet and Longevity
Current Nutrition & Food Science